All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings.
These reports are called 13F reports. However, the filings are required
the following quarter
from the reporting period,
which means that by the time the filing is made (and we see them), the information could be five months old.
For funds
with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover,
the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions
are identified in the table. However, they are not required to report short positions.
Click the link icon to see the full transaction history.
Upgrade
to unlock premium data and export to Excel 
.
| Security |
Imputed
Share Price |
Prev
Shares |
Current
Shares |
Change
(Percent) |
Prev Value
(USD x1000) |
Current Value
(USD x1000) |
Change
(Percent) |
|---|
| AVTX / Avalo Therapeutics, Inc.
|
|
|
|
|
|
|
|
| TYRA / Tyra Biosciences, Inc.
|
|
|
|
|
|
|
|
| SLNO / Soleno Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AVTE / Aerovate Therapeutics, Inc.
|
|
|
|
|
|
|
|
| NKTR / Nektar Therapeutics
|
|
|
|
|
|
|
|
| EYPT / EyePoint Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| SVRA / Savara Inc.
|
|
|
|
|
|
|
|
| TRML / Tourmaline Bio, Inc.
|
|
|
|
|
|
|
|
| MLYS / Mineralys Therapeutics, Inc.
|
|
|
|
|
|
|
|
| EWTX / Edgewise Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ANTX / AN2 Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ADVERUM BIOTECHNOLOGIES, INC.
/ COMM (00773U108) |
|
|
|
|
|
|
|
| VISTAGEN THERAPEUTICS INC
/ COMM (92840H202) |
|
|
|
|
|
|
|
| MDGL / Madrigal Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| CCCC / C4 Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SLNO / Soleno Therapeutics, Inc.
|
|
|
|
|
|
|
|
| AMLX / Amylyx Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| FULC / Fulcrum Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| TARS / Tarsus Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
| COGT / Cogent Biosciences, Inc.
|
|
|
|
|
|
|
|
| KOD / Kodiak Sciences Inc.
|
|
|
|
|
|
|
|
| XNCR / Xencor, Inc.
|
|
|
|
|
|
|
|
| OCUL / Ocular Therapeutix, Inc.
|
|
|
|
|
|
|
|
| MBX / MBX Biosciences, Inc.
|
|
|
|
|
|
|
|
| GPCR / Structure Therapeutics Inc. - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| CABA / Cabaletta Bio, Inc.
|
|
|
|
|
|
|
|
| KROS / Keros Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CGON / CG Oncology, Inc.
|
|
|
|
|
|
|
|
| THRD / Third Harmonic Bio, Inc.
|
|
|
|
|
|
|
|
| VTGN / Vistagen Therapeutics, Inc.
|
|
|
|
|
|
|
|
| CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| DYN / Dyne Therapeutics, Inc.
|
|
|
|
|
|
|
|
| SLN / Silence Therapeutics plc - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| VTYX / Ventyx Biosciences, Inc.
|
|
|
|
|
|
|
|
| KURA / Kura Oncology, Inc.
|
|
|
|
|
|
|
|
| ATXS / Astria Therapeutics, Inc.
|
|
|
|
|
|
|
|
| IRON / Disc Medicine, Inc.
|
|
|
|
|
|
|
|
| TRDA / Entrada Therapeutics, Inc.
|
|
|
|
|
|
|
|
| ABVX / ABIVAX Société Anonyme - Depositary Receipt (Common Stock)
|
|
|
|
|
|
|
|
| ADVM / Adverum Biotechnologies, Inc.
|
|
|
|
|
|
|
|
